Health Care Industry
Industry: Email Alert RSS FeedWatson's generic Vasotec gets OK
Drug Store News, June 26, 2000
The FDA has tentatively approved Watson's abbreviated new drug application for Enalapril Maleate tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg. Enalapril Maleate is the generic equivalent of Merck's ACE-inhibitor Vasotec. Watson said final approval of the ANDA may not be received prior to August 22, when pediatric exclusivity will expire.
Most RecentHealth Care Articles
Aventis, the firm's contract manufacturer, will produce the drug for Watson in Cincinnati. Eight other generic manufacturers, including ESI Lederle, Teva and Apothecon hold tentative approvals for generic formulations of Vasotec.
COPYRIGHT 2000 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2008 Gale, Cengage Learning
Brought to you by CBS MoneyWatch.com
- 10 Best Places to Retire
- Companies with the Best 401(k) Plans
- Most Important Document for Your Heirs? It's Not Your Will
- Video: Should You Expect to Retire Rich?
- Over 50? Here's How to Get (and Keep) a Great Job
Most Recent Health Articles
Most Recent Health Publications
Most Popular Health Articles
- Detox in 7 days: a detoux diet can help you shed up to 10 pounds and leave you feeling terrific. Our weeklong plan shows you how to lose the weight and keep it off - Cover story
- All about nightshades: explore the hidden hazards of your favorite food with macrobiotic nutritionist Lino Stanchich
- La anemia falciforme - causas y tratamiento
- The sour truth about apple cider vinegar - evaluation of therapeutic use
- Treat sinusitis naturally: breath easy and relieve sinus pressure with these remedies - Quick Fixes and Long-Term Solutions
Most Popular Health Publications
Content provided in partnership with http://findarticles.com/source//
Sponsored by Merrill Lynch